Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
Cash Flows From Operating Activities | |||||
Net Income | N/A | 480,200 | N/A | N/A | N/A |
Depreciation Amortization | N/A | 398,300 | N/A | N/A | N/A |
Other Working Capital | N/A | -129,100 | N/A | N/A | N/A |
Other Operating Activity | 0 | 767,500 | 0 | 0 | 0 |
Operating Cash Flow | $N/A | $1,516,900 | $N/A | $N/A | $N/A |
Cash Flows From Investing Activities | |||||
PPE Investments | N/A | -628,100 | N/A | N/A | N/A |
Net Acquisitions | N/A | -126,200 | N/A | N/A | N/A |
Other Investing Activity | 0 | -112,400 | 0 | 0 | 0 |
Investing Cash Flow | $N/A | $-866,700 | $N/A | $N/A | $N/A |
Cash Flows From Financing Activities | |||||
Dividend Paid | N/A | -708,400 | N/A | N/A | N/A |
Other Financing Activity | 0 | 185,300 | 0 | 0 | 0 |
Financing Cash Flow | $N/A | $-523,100 | $N/A | $N/A | $N/A |
Exchange Rate Effect | N/A | -19,900 | N/A | N/A | N/A |
Beginning Cash Position | N/A | 432,400 | N/A | N/A | N/A |
End Cash Position | N/A | 539,600 | N/A | N/A | N/A |
Net Cash Flow | $N/A | $107,200 | $N/A | $N/A | $N/A |
Free Cash Flow | |||||
Operating Cash Flow | N/A | 1,516,900 | N/A | N/A | N/A |
Free Cash Flow | 0 | 1,516,900 | 0 | 0 | 0 |